Keywords: positive, aventis, exubera, data, ada, franco-german, drugmaker
Positive Aventis' Exubera data at ADA
Article | 14 June 2004
Franco-German drugmaker Aventis presented positive clinical trial data on its antidiabetes product, Exubera (an inhalable, rapid-acting drug powder insulin), at ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
